Hydrochlorides and hydrates of 1-((3-cyanopyridin-2-yl)methyl)-3-methy l7-(2-butyn-1-yl)-8-(3-aminopiperidin-1-y l)xanthine, their preparation and their use as medicaments

Details for Australian Patent Application No. 2006274919 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Sieger, Peter; Pfrengle, Waldemar

Agent Davies Collison Cave

Pub. Number AU-A-2006274919

PCT Pub. Number WO2007/014886

Priority 10 2005 035 891.8 30.07.05 DE

Filing date 26 July 2006

Wipo publication date 8 February 2007

International Classifications

C07D 473/04 (2006.01) Heterocyclic compounds containing purine ring systems

A61K 31/522 (2006.01)

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

20 March 2008 PCT application entered the National Phase

  PCT publication WO2007/014886 Priority application(s): WO2007/014886

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006274924-Hydraulic circuit for instant beverage machines, relief and safety valve for said circuit and method for the preparation of instant beverages

2006274918-Antibacterial quinoline derivatives